BONE DISEASE IN β‐THALASSAEMIA MAJOR
Open Access
- 1 December 1998
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 103 (4) , 897-901
- https://doi.org/10.1046/j.1365-2141.1998.01107.x
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Nonassociation of Estrogen Receptor Genotypes with Bone Mineral Density and Estrogen Responsiveness to Hormone Replacement Therapy in Korean Postmenopausal WomenJournal of Clinical Endocrinology & Metabolism, 1997
- Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I α 1 geneNature Genetics, 1996
- Growth and development in thalassaemia major patients with severe bone lesions due to desferrioxamineEuropean Journal of Pediatrics, 1996
- Growth and development in thalassaemia major patients with severe bone lesions due to desferrioxamineEuropean Journal of Pediatrics, 1996
- Relationship between transfusion regimen and suppression of erythropoiesis in β‐thalassaemia majorBritish Journal of Haematology, 1995
- The contribution of hypogonadism to the development of osteoporosis in thalassaemia major: new therapeutic approachesClinical Endocrinology, 1995
- The development of oral and facial signs in beta-thalassaemia majorBritish Dental Journal, 1988
- Incidence and Treatment of Fractures in ThalassemiaJournal of Orthopaedic Trauma, 1988
- Serum 1,25 dihydroxyvitamin D and osteocalcin concentrations in thalassaemia major.Archives of Disease in Childhood, 1987
- PREVENTION OF BONE MALFORMATIONS AND CARDIOMEGALY IN COOLEY'S ANEMIA BY EARLY HYPERTRANSFUSION REGIMENAnnals of the New York Academy of Sciences, 1969